JP TSE 4599 Pharmaceutical

StemRIM Inc.

株式会社ステムリム

Fiscal year ends
Jul
Latest results
FY ending Jul 2026
Employees
48
Net income
−¥1.9B
≈ −$11.7M
Income taxes paid
¥8.3M
≈ $52K
Total assets
¥5.9B
≈ $37.4M
Equity ratio
96.7%
 

Ranked #3,760 among listed Japanese companies by corporate taxes paid.

US dollar amounts use ¥158.0 per dollar.

Annual results

Fiscal yearRevenueNet incomeTax expenseTaxes paidTotal assetsNet assetsEquity ratioSource
Jul 2026—−¥1.9B ¥2.0M¥8.3M ¥5.9B¥5.7B96.7% EDINET
Jul 2025—−¥1.9B ¥1.7M¥3.6M ¥7.5B¥7.3B97.3% EDINET
Jul 2024—−¥2.0B —— ¥9.1B¥8.9B98.0% EDINET
Jul 2023¥2.4B¥168M —— ¥10.7B¥10.4B96.9% EDINET
Jul 2022¥23.0M−¥1.9B —— ¥9.6B¥9.4B98.0% EDINET

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ(同業比較・役員)

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.

World rankings